Design Therapeutics, Inc.

Q3 2023 13F Holders

Symbol
DSGN
CUSIP
25056L103
Type
Equity
Class
COM
Num filings
94
Total reported value, excl. options
$77.7 M
Manager Report Date Value ($000) Shares Option Type